Related Experiment Video

Updated: Jun 20, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Regulation of stathmin phosphorylation in mouse liver progenitor-29 cells during proteasome inhibition

Enrique Santamaría1, Maria I Mora, Javier Muñoz

  • 1Center for Applied Medical Research, University of Navarra, Proteomics Laboratory, 31008 Pamplona, Spain.

Proteomics
|August 19, 2009
PubMed

Insights

Proteasome inhibitors induce apoptosis in liver cells by altering protein phosphorylation. This study identifies NDRG1 and stathmin as key phosphoproteins involved in the cellular response to proteasome inhibition.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Medicine

Background:

  • Proteasome inhibitors show therapeutic potential for liver diseases like hepatocarcinoma.
  • Understanding proteasome inhibitor-induced apoptosis mechanisms is crucial for drug development.
  • Altered protein phosphorylation may play a significant role in these mechanisms.

Purpose of the Study:

  • To investigate the impact of proteasome inhibitor MG132 on protein phosphorylation in mouse liver progenitor-29 (MLP-29) cells.
  • To identify key phosphoproteins involved in the cellular response to proteasome inhibition.
  • To elucidate the role of specific phosphoproteins, such as NDRG1 and stathmin, in proteasome inhibitor-induced apoptosis.

Main Methods:

  • Proteasome inhibitor MG132 treatment of MLP-29 cells.
  • Phosphoprotein affinity chromatography combined with Difference Gel Electrophoresis (DIGE).
  • Nano-liquid chromatography-tandem mass spectrometry (LC-MS/MS) for phosphoprotein identification and quantification.

Main Results:

  • Thirteen unique deregulated phosphoproteins were identified, involved in chaperone activity, stress response, mRNA processing, and cell cycle control.
  • Alterations in NDRG1 and stathmin phosphorylation were observed, suggesting their involvement in apoptosis.
  • Specific phosphorylation sites on stathmin (Ser16, Ser25, Ser38) were transiently modified, and this modification was also seen with epoxomicin treatment.

Conclusions:

  • Regulation of NDRG1 and stathmin phosphorylation is implicated in the cellular response to proteasome inhibitors.
  • The identified phosphoproteins and their altered phosphorylation patterns offer insights into the mechanisms of proteasome inhibitor-induced apoptosis.
  • Further research into stathmin and NDRG1 phosphorylation could lead to novel therapeutic strategies for liver diseases.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...